ArticleThe Journal of clinical investigation2021
The matrix metalloproteinase inhibitor IPR-179 has antiseizure and antiepileptogenic effects.
Diede Wm Broekaart et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
33 papers cite it
this papercites it